|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 颈动脉粥样硬化疾病的处理美国血管外科学会临床实践指南显示文摘美国血管外科学会(SVS)任命了一个专家委员会制定颈动脉狭窄处理的循证临床指南。在制定临床实践推荐意见过程中,该委员会使用系统评价对当前最件的证据进行了总结,采用GRADE标准对推荐意见的强度(强烈推荐为GRADEI级,一般推荐为GRADEⅡ级)和证据的质量(高、中、低和极低)进行了分级。对于轻度颈动脉狭窄患者(有症状患者狭窄程度〈50%和无症状患者狭窄程度〈60%),推荐进行最佳的内科治疗而非血管重建术(I级推荐,高质量证据)。对于有症状中到重度狭窄患者(狭窄程度≥50%),推荐行颈动脉内膜切除术(CEA)+最佳的内科治疗(I级推荐,高质量证据)。对于围手术期风险高的有症状巾到重度狭窄患者(狭窄程度≥50%),建议采用颈动脉支架置入术作为其替代治疗手段(Ⅱ级推荐,低质量证据)。对于中到重度狭窄的无症状患者(狭窄程度≥60%),只要围手术期风险较低,就推荐行CEA+内科治疗(I级推荐,高质量证据)。对于中到重度狭窄的尢症状患者(狭窄稗度≥60%),不推荐行颈动脉支架置入术(I级推荐,低质量证据)。颈动脉狭窄≥80%但存在CEA高危解剖学风险的患者可能是一个例外。 | Robert W. Hobson, Ⅱ William C. Mackey Enrico Ascher M. Hassan Murad Keith D. Calligaro Anthony J. Comerota Victor M. Montori Mark K. Eskandari Douglas W. Massop Ruth L. Bush Brajesh K. Lal Bruce A. Perler 刘德志(译) 徐格林(译) 刘新峰(译) | 2008 | 国际脑血管病杂志2008，16，12： | 35 |
| 2 | 2018年急性缺血性卒中患者早期管理指南美国心脏协会/美国卒中协会为医疗专业人员制定的指南显示文摘背景和目的本指南旨在在单个文件中为治疗成年急性动脉性缺血性卒中患者的临床医生提供最新全面的系列推荐意见。目标读者为院前急救人员、医生、综合医疗保健人员和医院管理人员。本指南将取代2013年版指南及其后续更新。方法写作组成员由美国心脏协会卒中委员会的科学声明监督委员任命,代表各领域的医学专家。严格遵循美国心脏协会的利益冲突原则。不允许写作组成员对存在企业利益关系的相关议题进行讨论或投票。所有推荐意见必须得到写作组成员的一致通过,除非企业利益关系妨碍了成员投票。由4名同行评议专家以及卒中委员会的科学声明监督委员会和领导委员会成员对指南草案进行发布前评审。本指南采用了美国心脏病学学会/美国心脏协会2015年推荐意见分类和证据级别标准以及新版美国心脏协会指南格式。结果本指南详细介绍了院前医疗、紧急和急诊评估、静脉和血管内治疗以及院内管理,包括在发病后最初2周内启用的二级预防措施。本指南支持院前和院内卒中医疗系统的一体化概念。结论本指南基于目前可获得的最佳证据。然而,许多情况资料有限,迫切需要对急性缺血性卒中的治疗进行持续研究。 | William J. Powers Alejandro A. Rabinstein Teri Ackerson Opeolu M. Adeoye Nicholas C. Bambakidis Kyra Becker José Biller Michael Brown Bart M. Demaerschalk Brian Hoh Edward C. Jauch Chelsea S. Kidwell Thabele M. Leslie-Mazwi Bruce Ovbiagele Phillip A. Scott Kevin N. Sheth Andrew M. Southerland Deborah V. Summers David L. Tirschwell 徐加平 刘慧慧 张霞 石际俊 黄志超 尤寿江 郭志良 肖国栋 杜万良 曹勇军 | 2018 | 国际脑血管病杂志2018，26，2： | 19 |
| 3 | 2019年急性缺血性卒中患者早期管理指南:针对2018年急性缺血性卒中早期管理指南的更新美国心脏协会/美国卒中协会为医疗专业人员制定的指南显示文摘背景和目的本指南旨在在单个文件中为治疗急性动脉性缺血性卒中患者的临床医生提供最新的全面系列推荐意见。目标读者为院前急救人员、医生、综合医疗保健人员以及医院管理人员。本指南将取代2013年版急性缺血性卒中(acute ischemic stroke,AIS)指南,同时也是对2018年版AIS指南的更新。方法写作组成员由美国心脏协会(American Heart Association,AHA)卒中委员会的科学声明监督委员会任命,代表各领域的医学专家。写作组成员不得对存在企业利益关系的相关议题进行讨论或投票。对2013年版AIS指南的更新最初于2018年1月发表,该版指南已经过AHA科学咨询与协调委员会以及AHA执行委员会批准。2018年4月,在删除部分推荐意见后,该指南的修订版在AHA网站上在线发表。要求写作组审查原始文件并在必要时进行修订。2018年6月,写作组提交了一份经过细微更改并纳入新近发表的重要随机对照试验(受试者数量>100名且具有AIS发病后至少90 d的临床转归)的文件。经过14位专家进行同行评议后,写作组根据同行评议专家的意见进行了适当修改。目前的最终文件已经过写作组全体成员(除非企业利益关系妨碍了成员投票)以及AHA管理机构批准。本指南采用了美国心脏病学学会/AHA 2015年推荐意见分类和证据级别标准以及新版AHA指南格式。结果本指南详细介绍了院前医疗、紧急和急诊评估、静脉和血管内治疗以及院内管理,包括在发病后最初2周内启用的二级预防措施。本指南支持院前和院内卒中医疗系统的一体化概念。结论本指南基于现有证据提供了总体推荐意见,用于指导治疗成年急性动脉性缺血性卒中患者的临床医生。然而,许多情况资料有限,迫切需要对AIS的治疗进行持续研究。 | William J.Powers Alejandro A.Rabinstein Teri Ackerson Opeolu M.Adeoye Nicholas C.Bambakidis Kyra Becker Jose Biller Michael Brown Bart M.Demaerschalk Brian Hoh Edward C.Jauch Chelsea S.Kidwell Thabele M.Leslie-Mazwi Bruce Ovbiagele Phillip A.Scott Kevin N.Sheth Andrew M.Southerl Deborah V.Summers Tirschwell 徐加平(译) 庄圣(译) 郭志良(译) 黄志超(译) 尤寿江(译) 刘慧慧(译) 张霞(译) 石际俊(译) 肖国栋(译) 曹勇军(译) 刘春风(译) | 2020 | 国际脑血管病杂志2020，28，1： | 18 |
| 4 | Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome显示文摘AIM:To design and validate broad-range 16S rRNA primers for use in high throughput sequencing to classify bacteria isolated from the human foregut microbiome.METHODS:A foregut microbiome dataset was constructed using 16S rRNA gene sequences obtained from oral,esophageal,and gastric microbiomes produced by Sanger sequencing in previous studies represented by 219 bacterial species.Candidate primers evaluated were from the European rRNA database.To assess the effect of sequence length on accuracy of classification,16S rRNA genes of various lengths were created by trimming the full length sequences.Sequences spanning various hypervariable regions were selected to simulate the amplicons that would be obtained using possible primer pairs.The sequences were compared with full length 16S rRNA genes for accuracy in taxonomic classification using online software at the Ribosomal Database Project (RDP).The universality of the primer set was evaluated using the RDP 16S rRNA database which is comprised of 433 306 16S rRNA genes,represented by 36 phyla.RESULTS:Truncation to 100 nucleotides(nt)downstream from the position corresponding to base 28 in the Escherichia coli 16S rRNA gene caused misclassification of 87(39.7%)of the 219 sequences,compared with misclassification of only 29(13.2%)sequences with truncation to 350 nt.Among 350-nt sequence reads within various regions of the 16S rRNA gene,the reverse read of an amplicon generated using the 343F/798R primers had the least(8.2%)effect on classification.In comparison,truncation to 900 nt mimicking single pass Sanger reads misclassified 5.0%of the 219 sequences.The 343F/798R amplicon accurately assigned 91.8%of the 219 sequences at the species level.Weighted by abundance of the species in the esophageal dataset,the 343F/798R amplicon yielded similar classification accuracy without a significant loss in species coverage(92%).Modification of the 343F/798R primers to 347F/803R increased their universality among foregut species.Assuming that a typicalpolymerase chain reaction can tolerate 2 mismatches between a primer and a template,the modified 347F and 803R primers should be able to anneal 98%and 99.6%of all 16S rRNA genes in the RDP database.CONCLUSION:347F/803R is the most suitable pair of primers for classification of foregut 16S rRNA genes but also possess universality suitable for analyses of other complex microbiomes. | Carlos W Nossa William E Oberdorf Jφrn A Aas Bruce J Paster Todd Z DeSantis Eoin L Brodie Daniel Malamud Michael A Poles Zhiheng Pei | 2010 | World Journal of Gastroenterology2010，16，33： | 16 |
| 5 | Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review显示文摘Neuroendocrine tumors(NET)previously called carcinoid tumors are neoplasms of enterochromaffin/neuroendocrine cell origin which display neurosecretory capacity that may result in the carcinoid syndrome.The annual incidence of patients with NET is 8.4 per 100000;yet many NET remain asymptomatic and clinically undetected.A majority of NET follows a benign course;however,some will display malignant characteristics.NET most commonly occur in the gastrointestinal tract(67%)and bronchopulmonary system(25%).Gastrointestinal NET occur within the stomach,small intestine,liver,and rectum.We report a retrospective study of 11 subjects:Eight with benign carcinoid tumors:duodenal bulb(n=2),terminal ileum(n=1),sigmoid colon(n=2),and rectum(n=3);three with malignant carcinoid:liver(n=1)and intra-abdominal site(n=2).The diagnosis,endoscopic images,outcome,treatment and review of the literature are presented. | William J Salyers Kenneth J Vega Juan Carlos Munoz Bruce W Trotman Silvio S Tanev | 2014 | World Journal of Gastrointestinal Oncology2014，6，8： | 8 |
| 6 | 颈动脉粥样硬化疾病的处理 美国血管外科学会临床实践指南显示文摘美国血管外科学会(SVS)任命了一个专家委员会制定颈动脉狭窄处理的循证临床指南。在制定临床实践推荐意见过程中,该委员会使用系统评价对当前最佳的证据进行了总结,采用GRADE标准对推荐意见的强度(强烈推荐为GRADEⅠ级,一般推荐为GRADEⅡ级)和证据的质量(高、中、低和极低)进行了分级。对于轻度颈动脉狭窄患者(有症状患者狭窄程度<50%和无症状患者狭窄程度<60%),推荐进行最佳的内科治疗而非血管重建术(Ⅰ级推荐,高质量证据)。对于有症状中到重度狭窄患者(狭窄程度≥50%),推荐行颈动脉内膜切除术(CEA)+最佳的内科治疗(Ⅰ级推荐,高质量证据)。对于围手术期风险高的有症状中到重度狭窄患者(狭窄程度≥50%),建议采用颈动脉支架置入术作为其替代治疗手段(Ⅱ级推荐,低质量证据)。对于中到重度狭窄的无症状患者(狭窄程度≥60%),只要围手术期风险较低,就推荐行CEA+内科治疗(Ⅰ级推荐,高质量证据)。对于中到重度狭窄的无症状患者(狭窄程度≥60%),不推荐行颈动脉支架置入术(Ⅰ级推荐,低质量证据)。颈动脉狭窄≥80%但存在CEA高危解剖学风险的患者可能是一个例外。 | Robert W.Hobson Ⅱ William C.Mackey Enrico Ascher M.Hassan Murad Keith D.Calligaro Anthony J.Comerota Victor M.Montori Mark K.Eskandari Douglas W.Massop Ruth L.Bush Brajesh K.Lal Bruce A.Perler 刘德志 徐格林 刘新峰 | 2008 | 中华脑血管病杂志(电子版)2008，2，6： | 6 |
| 7 | Discussions on rockburst and dynamic ground support in deep mines显示文摘The paper is a summary of discussions on four topics in rockburst and dynamic ground support.Topic 1 is the mechanisms of rockburst.Rockburst events are classified into two categories in accordance with the triggering mechanisms,i.e.strain burst and fault-slip burst.Strain burst occurs on rock surfaces when the tangential stress exceeds the rock strength in hard and brittle rocks.Fault-slip burst is triggered by fault-slip induced seismicity.Topic 2 is prediction and forecasting of rockburst events.Prediction for a rockburst event must tell the location,timing and magnitude of the event.Forecasting could simply foresee the probability of some of the three parameters.It is extremely challenging to predict rockbursts and large seismic events with current knowledge and technologies,but forecasting is possible,for example the possible locations of strain burst in an underground opening.At present,the approach using seismic monitoring and numerical modelling is a promising forecasting method.Topic 3 is preconditioning methods.The current preconditioning methods are blasting,relief-hole drilling and hydrofracturing.Defusing fault-slip seismicity is difficult and challenging but has been achieved.In very deep locations(>3000 m),the fracturing could extend from the excavation face to a deep location ahead of the face and therefore preconditioning is usually not required.Topic 4 is dynamic ground support against rockburst.Dynamic ground support requires that the support system be strong enough to sustain the momentum of the ejecting rock on one hand and tough enough on the other hand to absorb the strain and seismic energies released from the rock mass.The current dynamic support systems in underground mining are composed of yielding tendons and flexible surface retaining elements like mesh/screen and straps.Yielding props and engineered timber props are also used for dynamic support. | Charlie C.Li Peter Mikula Brad Simser Bruce Hebblewhite William Joughin Xiaowei Feng Nuwen Xu | 2019 | Journal of Rock Mechanics and Geotechnical Engineering2019，11，5： | 5 |
| 8 | Long‐term infliximab maintenance therapy for ulcerative colitis: The ACT‐1 and ‐2 extension studies显示文摘 | WalterReinisch William J.Sandborn PaulRutgeerts Brian G.Feagan DanielRachmilewitz Stephen B.Hanauer Gary R.Lichtenstein Willem J.S.de Villiers MarionBlank YinghuaLang JewelJohanns Jean FrédéricColombel DanielPresent Bruce E.Sands | 2012 | Inflamm Bowel Dis2012，，2： | 3 |
| 9 | Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis显示文摘 | Jean Frédéric Colombel Paul Rutgeerts Walter Reinisch Dirk Esser Yanxin Wang Yinghua Lang Colleen W. Marano Richard Strauss Bj?rn J. Oddens Brian G. Feagan Stephen B. Hanauer Gary R. Lichtenstein Daniel Present Bruce E. Sands William J. Sandborn | 2011 | Gastroenterology2011，，4： | 3 |
| 10 | Gastric adenocarcinoma in patients 40 years of age or younger显示文摘 | Charles P. Theuer Christian de Virgilio Greg Keese Samuel French Tracey Arnell Jorge Tolmos Stanley Klein William Powers Tony Oh Bruce E. Stabile | 1996 | The American Journal of Surgery1996，，5： | 2 |
| 11 | Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry显示文摘 | Gary R. Lichtenstein Brian G. Feagan Russell D. Cohen Bruce A. Salzberg Robert H. Diamond Donny M. Chen Michelle L. Pritchard William J. Sandborn | 2006 | Clinical Gastroenterology and Hepatology2006，，5： | 2 |
| 12 | 新转化膜在汽车行业内的应用近况显示文摘过去60年间,化学公司一直为汽车制造商提供最先进的磷酸锌转化膜,若将该转化膜适当地用于金属表面,可增强漆膜的附着力和防腐蚀性。磷酸盐转化膜在过去几年中经历了多次变革,目前,该转化膜的一些主要成分及副产品在新的环境政策下受到更加严格的控制,金属及其处理行业现在面临着将传统的磷酸锌膜替换为新一代产品的挑战。本文将介绍新一代氧化锆转化膜的优势,并讨论其性能和工艺成本的节省情况。过去数年内,该技术获得了极大进展,2007年几条新转化膜商业生产线已经开始试运行。文中还将展示这些试行生产线的成果,并讨论该技术的未来发展。 | Terrence R.Giles Bruce H.Goodreau William E.Fristad Jens Kroemer Michael Frank | 2008 | 汽车工艺与材料2008，，11： | 2 |
| 13 | The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses显示文摘 | Craig Margulies Eduardo Sampaio Siqueira William Bruce Silverman Xue Sen Lin John Anthony Martin Mordechai Rabinovitz Adam Slivka | 1999 | Gastrointestinal Endoscopy1999，，6： | 2 |
| 14 | “Can you see the real me?” A self-based model of authentic leader and follower development显示文摘 | William L. Gardner Bruce J. Avolio Fred Luthans Douglas R. May Fred Walumbwa | 2005 | The Leadership Quarterly2005，，3： | 2 |
| 15 | Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Had Failed显示文摘 | Bruce E. Sands Brian G. Feagan Paul Rutgeerts Jean-Frédéric Colombel William J. Sandborn Richmond Sy Geert D’Haens Shomron Ben-Horin Jing Xu Maria Rosario Irving Fox Asit Parikh Catherine Milch Stephen Hanauer | 2014 | Gastroenterology2014，，： | 2 |
| 16 | A new perspective on quiet Sun magnetism显示文摘The Hinode mission has provided us with a new, quantitative view of the magnetism of the quiet Sun. It has revealed that the quiet internetwork areas are blanketed by horizontal fields that appear at first sight to have more flux than the vertical fields resolved on the same 0.3 size scale. These measurements point to the possibility that the horizontal fields might be the primary source of the 'hidden turbulent flux' of the quiet Sun anticipated from Hanle effect depolarization. In this paper, evidence is presented suggesting that the 'seething' horizontal fields observed by Harvey in 2007 and the horizontal fields revealed by Hinode are the same phenomenon. Because the seething fields appear to be of uniform fluctuation over the whole disk, the phenomenon is most likely not associated with the dynamo source of solar activity. Thus, the small-scale 'hidden turbulent flux' lends support to the notion of a local solar dynamo acting on granular sizes and time scales. | LITES Bruce William | 2009 | Science China(Physics,Mechanics & Astronomy)2009，52，11： | 2 |
| 17 | Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial显示文摘 | Faramarz Ismail-Beigi Timothy Craven Mary Ann Banerji Jan Basile Jorge Calles Robert M Cohen Robert Cuddihy William C Cushman Saul Genuth Richard H Grimm Bruce P Hamilton Byron Hoogwerf Diane Karl Lois Katz Armand Krikorian Patrick O'Connor Rodica Pop-Bus | 2010 | The Lancet2010，，9739： | 2 |
| 18 | Analysis of feline calicivirus capsid protein genes:identification of varia ble antigenic determinant regions of the protein显示文摘 | Bruce S S Julia F R William L M | 1993 | J Gen Virol1993，74，： | 1 |
| 19 | Authentic leadership development: Getting to the root of positive forms of leadership显示文摘 | Bruce J. Avolio William L. Gardner | 2005 | The Leadership Quarterly2005，，3： | 1 |
| 20 | Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals显示文摘 | Harry Olson Graham Betton Denise Robinson Karluss Thomas Alastair Monro Gerald Kolaja Patrick Lilly James Sanders Glenn Sipes William Bracken Michael Dorato Koen Van Deun Peter Smith Bruce Berger Allen Heller | 2000 | Regulatory Toxicology and Pharmacology2000，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员